This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health (CYH) Hits 52-Week High on Solid Q4 Results
by Zacks Equity Research
Community Health (CYH) reaches a 52-week high in Friday's trading session, backed by its strong fourth-quarter earnings performance.
What's in Store for Select Medical's (SEM) Q4 Earnings?
by Zacks Equity Research
Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.
New Strong Buy Stocks for January 31st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Is Select Medical (SEM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Select Medical Holdings (SEM) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
New Strong Buy Stocks for January 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Select Medical (SEM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Select Medical (SEM) closed at $24.15, marking a +1.09% move from the previous day.
Select Medical (SEM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Select Medical (SEM) closed at $24.20, marking a +1.81% move from the previous day.
Select Medical (SEM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Select Medical (SEM) closed at $23.23, marking a +0.65% move from the previous day.
Select Medical (SEM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Select Medical (SEM) closed at $23.32, marking a +0.6% move from the previous day.
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Will Select Medical's Solid Run in 2019 Sustain in 2020?
by Zacks Equity Research
Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.
Select Medical (SEM) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
In the latest trading session, Select Medical (SEM) closed at $23.10, marking a -0.17% move from the previous day.
The Zacks Analyst Blog Highlights: Installed Building Products, Universal Forest, Insight, Meritage Homes and Select Medical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Installed Building Products, Universal Forest, Insight, Meritage Homes and Select Medical
5 Must-Buy Top-Ranked Mid-Cap Stocks for 2020
by Nalak Das
The U.S. economy is in good shape with a robust labor market, higher consumer spending and a dovish monetary stance taken by the Fed.
The Zacks Analyst Blog Highlights: TopBuild, Comfort Systems, Installed Building Products, Universal Forest and Select Medical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TopBuild, Comfort Systems, Installed Building Products, Universal Forest and Select Medical
Has Select Medical Holdings (SEM) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
Cigna to Divest Non-Health Unit, Streamline Operations
by Zacks Equity Research
Cigna (CI) announces sale of its Group Life and Disability business to focus on debt reduction and core business of healthcare.
Real Santa Rally Comes After Christmas: 5 Solid Buys
by Tirthankar Chakraborty
Courtesy of positive seasonal trend, the passage of the USMCA trade deal to replace NAFTA, US-China trade truce and improving economic data, we are lined up for a strong year-end rally.
Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives
by Zacks Equity Research
Ensign Group (ENSG) clears a quarterly dividend hike to share more profits with investors.
The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita
5 Healthcare Stocks to Keep the Winning Streak Alive in 2020
by Sapna Bagaria
Increasing incidence of chronic diseases, aging U.S. population, innovation and consolidation will drive the healthcare industry's growth in 2020.
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Humana (HUM) to Take Over Enclara for Enriched Healthcare
by Zacks Equity Research
Humana (HUM) to acquire hospice pharmacy Enclara Healthcare for boosting its capabilities.